• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
76,913.50 -582.86
( -0.75%)
Global Indices
Nasdaq
49,530.46 -142.69
(-0.29%)
Dow Jones
7,252.74 22.73
(0.31%)
Hang Seng
59,594.47 309.55
(0.52%)
Nikkei 225
10,375.34 -3.48
(-0.03%)
Forex
USD-INR
94.96 0.17
(0.17%)
EUR-INR
111.11 0.25
(0.23%)
GBP-INR
128.48 0.55
(0.43%)
JPY-INR
0.60 0.01
(1.28%)

EQUITY - MARKET SCREENER

Aarti Drugs Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
524348
INE767A01016
147.0110661
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
AARTIDRUGS
18.43
3423.08
EPS(TTM)
Face Value()
Div & Yield %
20.35
10
0.27
 

CCI approves acquisition of controlling stake in Sammaan Capital by Avenir Investment RSC
Dec 10,2025
Sammaan Capital announced that the Competition Commission of India has approved the proposed acquisition of controlling stake in the company by Avenir Investment RSC (Investor), which is owned and controlled by International Holding Company PJSC (Proposed Transaction).

The only regulatory approvals pending for consummation of the Proposed Transaction are from (a) the Securities and Exchange Board of India for the Open Offer by the Investor and other related approvals and (b) the Reserve Bank of India, for which the Company and the Investor are in active engagement with the respective regulators to ensure expeditious receipt of the approvals, towards timely completion of the Proposed Transaction.